Form 4 for XRAY DENTSPLY SIRONA Inc.
Accepted 2024-03-06 00:00:00 ET · period of report 2024-03-04 · accession 0001127602-24-008823 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-06 | 2024-03-04 | XRAY | Coleman Glenn | CFO, Executive VP | A - Grant | $0.00 | +18.8K | 88.4K | +27% | $0 |
| D | 2024-03-06 | 2024-03-04 | XRAY | Coleman Glenn | CFO, Executive VP | A - Grant | $0.00 | +62.8K | 62.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-04 | A | A | 18,780 | $0.00 | 88,449.01 | D | — | — | (F1) Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending 3/4/2027. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-03-04 | A | A | 62,800 | $0.00 | 62,800 | D | $33.28 · — to 2034-03-04 | 62,800 Common Stock | (F2) Stock options vest in annual one-third (1/3) increments over a three (3) year period ending March 4, 2027. |